📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies. (2020)

First Author: Liu P

Attributed to: Epidemiology and treatment outcomes of endometrial hyperplasia and cancer: A population-based investigation using routine administrative data funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-020-0860-4

PubMed Identifier: 32367073

Publication URI: http://europepmc.org/abstract/MED/32367073

Type: Journal Article/Review

Volume: 123

Parent Publication: British journal of cancer

Issue: 2

ISSN: 0007-0920